Andrew D. Ludwig

468 total citations
13 papers, 332 citations indexed

About

Andrew D. Ludwig is a scholar working on Neurology, Cancer Research and Molecular Biology. According to data from OpenAlex, Andrew D. Ludwig has authored 13 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 5 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Andrew D. Ludwig's work include Neuroblastoma Research and Treatments (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Andrew D. Ludwig is often cited by papers focused on Neuroblastoma Research and Treatments (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Andrew D. Ludwig collaborates with scholars based in United States, Canada and Germany. Andrew D. Ludwig's co-authors include Jason M. Shohet, John Hicks, Zaowen Chen, Eveline Barbieri, Eugene S. Kim, Danielle Patterson, Mary L. Brandt, Daniel I. Feig, Darrell L. Cass and Andrew Slack and has published in prestigious journals such as Cancer Research, Oncogene and Scientific Reports.

In The Last Decade

Andrew D. Ludwig

13 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew D. Ludwig United States	10	176	127	122	105	46	13	332
K Ito Japan	9	196 1.1×	92 0.7×	29 0.2×	94 0.9×	48 1.0×	15	351
Ernst-Otto Riecken Germany	7	159 0.9×	35 0.3×	35 0.3×	148 1.4×	56 1.2×	7	360
Baoan Hong China	11	292 1.7×	265 2.1×	24 0.2×	77 0.7×	47 1.0×	33	455
Autumn L. Jackson United States	4	149 0.8×	155 1.2×	20 0.2×	140 1.3×	22 0.5×	6	355
Shazia Irshad United Kingdom	9	209 1.2×	110 0.9×	11 0.1×	100 1.0×	28 0.6×	12	356
Mariangela Balistreri Italy	10	270 1.5×	219 1.7×	7 0.1×	124 1.2×	72 1.6×	15	487
Christine Challen United Kingdom	7	213 1.2×	117 0.9×	114 0.9×	187 1.8×	65 1.4×	12	374
Z. Jiang United States	6	153 0.9×	86 0.7×	11 0.1×	66 0.6×	23 0.5×	10	351
Ozlem Senol United States	4	290 1.6×	243 1.9×	50 0.4×	39 0.4×	22 0.5×	4	406

Countries citing papers authored by Andrew D. Ludwig

Since Specialization

Citations

This map shows the geographic impact of Andrew D. Ludwig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Ludwig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Ludwig more than expected).

Fields of papers citing papers by Andrew D. Ludwig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. Ludwig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Ludwig. The network helps show where Andrew D. Ludwig may publish in the future.

Co-authorship network of co-authors of Andrew D. Ludwig

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. Ludwig. A scholar is included among the top collaborators of Andrew D. Ludwig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. Ludwig. Andrew D. Ludwig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Labadie, Kevin P., Aimee L. Kenoyer, Donald K. Hamlin, et al.. (2023). Glypican-3 targeted positron emission tomography detects sub-centimeter tumors in a xenograft model of hepatocellular carcinoma. EJNMMI Research. 13(1). 35–35. 3 indexed citations

Labadie, Kevin P., Donald K. Hamlin, Aimee L. Kenoyer, et al.. (2021). Glypican-3–Targeted ²²⁷Th α-Therapy Reduces Tumor Burden in an Orthotopic Xenograft Murine Model of Hepatocellular Carcinoma. Journal of Nuclear Medicine. 63(7). 1033–1038. 20 indexed citations

Labadie, Kevin P., Andrew D. Ludwig, Donald K. Hamlin, et al.. (2021). Glypican-3 targeted delivery of 89Zr and 90Y as a theranostic radionuclide platform for hepatocellular carcinoma. Scientific Reports. 11(1). 3731–3731. 14 indexed citations

Ludwig, Andrew D., Kevin P. Labadie, Yongwoo David Seo, et al.. (2019). Yttrium-90-Labeled Anti-Glypican 3 Radioimmunotherapy Halts Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular Carcinoma. Journal of Oncology. 2019. 1–7. 12 indexed citations

Beckers, Anneleen, Andrew D. Ludwig, Gert Van Peer, et al.. (2014). The MYCN/miR-26a-5p/LIN28B regulatory axis controls MYCN-driven LIN28B upregulation in neuroblastoma. Ghent University Academic Bibliography (Ghent University). 1 indexed citations

Shohet, Jason M., Rajib Ghosh, Cristian Coarfa, et al.. (2011). A Genome-Wide Search for Promoters That Respond to Increased MYCN Reveals Both New Oncogenic and Tumor Suppressor MicroRNAs Associated with Aggressive Neuroblastoma. Cancer Research. 71(11). 3841–3851. 57 indexed citations

Patterson, Danielle, Brett A. Johnson, Andrew D. Ludwig, et al.. (2011). Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma. Angiogenesis. 14(3). 255–266. 56 indexed citations

Shang, Xiaoying, Sanjeev A. Vasudevan, Yang Yu, et al.. (2010). Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma. Oncogene. 29(35). 4938–4946. 47 indexed citations

Vasudevan, Sanjeev A., Ningling Ge, Heidi V. Russell, et al.. (2009). Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastoma. Molecular Cancer Therapeutics. 8(8). 2478–2489. 10 indexed citations

10.

Chen, Zaowen, Yunfu Lin, Eveline Barbieri, et al.. (2009). Mdm2 Deficiency Suppresses MYCN-Driven Neuroblastoma Tumorigenesis In Vivo. Neoplasia. 11(8). 753–762. 42 indexed citations

11.

Ludwig, Andrew D., et al.. (2007). Recent advances in the diagnosis and treatment of pheochromocytoma in children. The American Journal of Surgery. 194(6). 792–797. 41 indexed citations

12.

Slack, Andrew, Zaowen Chen, Andrew D. Ludwig, John Hicks, & Jason M. Shohet. (2007). MYCN-Directed Centrosome Amplification Requires MDM2-Mediated Suppression of p53 Activity in Neuroblastoma Cells. Cancer Research. 67(6). 2448–2455. 28 indexed citations

13.

Ludwig, Andrew D., et al.. (1995). [Solitary bone cysts. The pathogenesis, clinical picture and therapy of solitary bone cysts].. PubMed. 105(1). 63–70. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact